![Chris Sampson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Sampson
Keine laufenden Positionen mehr
Profil
Chris Sampson worked as a Director of Corporate Communications at BTG Ltd.
from 2015 to 2021.
He also worked as a Media Relations Contact at AstraZeneca PLC.
Ehemalige bekannte Positionen von Chris Sampson
Unternehmen | Position | Ende |
---|---|---|
BTG | Public Communications Contact | 01.03.2021 |
ASTRAZENECA PLC | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
BTG Ltd.
![]() BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |